BACKGROUND: Topical treatments with nasal saline irrigation, topical steroid sprays, or corticosteroid rinses can improve sinonasal symptoms in chronic rhinosinusitis (CRS). However, the impact of these therapies on commensals (Corynebacterium) and on biofilm pathogens associated with CRS (Staphylococcus aureus and Pseudomonas) is not well characterized. METHODS: Paired nasal and sinus swabs were collected endoscopically from 28 controls and 14 CRS patients with nasal polyposis (CRSwNP) who had not received systemic antibiotics or corticosteroids in the previous 8 weeks. Total DNA from swab eluents were extracted and analyzed by 16S rRNA gene-based pyrosequencing. A total of 359,077 reads were obtained and classified taxonomically. The association of use of topical therapies with sinonasal microbiota composition was assessed by factor/vector-fitting. The proportional abundances of sinonasal bacteria between topical therapy users and nonusers were further compared by 2-tailed Kolmogorov-Smirnov test among controls and among CRSwNP participants. RESULTS: Nasal saline irrigation, with or without added budesonide, was not associated with significantly distinct sinonasal microbiota composition or significantly decreased Pseudomonas or S. aureus abundances among either controls or CRSwNP participants. Corynebacterium was slightly lower in controls that reported using saline irrigation than those who did not. No significant association was found between nasal saline irrigation and the proportional abundances of Pseudomonas, S. aureus, and Corynebacterium in CRSwNP participants. However, male CRSwNP patients were noted to have significantly higher Corynebacterium proportional abundances than their female counterparts. The use of topical steroid sprays was associated with a distinct microbiota in control subjects, characterized by higher proportional abundances of Dolosigranulum and Simonsiella and a lower proportional abundance of Campylobacter. CONCLUSION: Nasal saline irrigation is not associated with a distinct alteration in the proportional abundance of commensal bacteria or biofilm-forming pathogens in CRSwNP patients. However, use of topical intranasal corticosteroid sprays in control subjects is associated with a distinct sinonasal microbiota.
BACKGROUND: Topical treatments with nasal saline irrigation, topical steroid sprays, or corticosteroid rinses can improve sinonasal symptoms in chronic rhinosinusitis (CRS). However, the impact of these therapies on commensals (Corynebacterium) and on biofilm pathogens associated with CRS (Staphylococcus aureus and Pseudomonas) is not well characterized. METHODS: Paired nasal and sinus swabs were collected endoscopically from 28 controls and 14 CRSpatients with nasal polyposis (CRSwNP) who had not received systemic antibiotics or corticosteroids in the previous 8 weeks. Total DNA from swab eluents were extracted and analyzed by 16S rRNA gene-based pyrosequencing. A total of 359,077 reads were obtained and classified taxonomically. The association of use of topical therapies with sinonasal microbiota composition was assessed by factor/vector-fitting. The proportional abundances of sinonasal bacteria between topical therapy users and nonusers were further compared by 2-tailed Kolmogorov-Smirnov test among controls and among CRSwNP participants. RESULTS:Nasal saline irrigation, with or without added budesonide, was not associated with significantly distinct sinonasal microbiota composition or significantly decreased Pseudomonas or S. aureus abundances among either controls or CRSwNP participants. Corynebacterium was slightly lower in controls that reported using saline irrigation than those who did not. No significant association was found between nasal saline irrigation and the proportional abundances of Pseudomonas, S. aureus, and Corynebacterium in CRSwNP participants. However, male CRSwNP patients were noted to have significantly higher Corynebacterium proportional abundances than their female counterparts. The use of topical steroid sprays was associated with a distinct microbiota in control subjects, characterized by higher proportional abundances of Dolosigranulum and Simonsiella and a lower proportional abundance of Campylobacter. CONCLUSION:Nasal saline irrigation is not associated with a distinct alteration in the proportional abundance of commensal bacteria or biofilm-forming pathogens in CRSwNP patients. However, use of topical intranasal corticosteroid sprays in control subjects is associated with a distinct sinonasal microbiota.
Authors: Neil C-W Tan; Andrew Foreman; Camille Jardeleza; Richard Douglas; Hai Tran; Peter John Wormald Journal: Laryngoscope Date: 2012-05-01 Impact factor: 3.325
Authors: Anthony A Prince; Jacob D Steiger; Ayesha N Khalid; Laurel Dogrhamji; Christine Reger; Steven Eau Claire; Alexander G Chiu; David W Kennedy; James N Palmer; Noam A Cohen Journal: Am J Rhinol Date: 2008 May-Jun
Authors: Miling Yan; Sünje J Pamp; Julia Fukuyama; Peter H Hwang; Do-Yeon Cho; Susan Holmes; David A Relman Journal: Cell Host Microbe Date: 2013-12-11 Impact factor: 21.023
Authors: Nicole A Abreu; Nabeetha A Nagalingam; Yuanlin Song; Frederick C Roediger; Steven D Pletcher; Andrew N Goldberg; Susan V Lynch Journal: Sci Transl Med Date: 2012-09-12 Impact factor: 17.956
Authors: Melissa A Pynnonen; Shraddha S Mukerji; H Myra Kim; Meredith E Adams; Jeffrey E Terrell Journal: Arch Otolaryngol Head Neck Surg Date: 2007-11
Authors: Debby Bogaert; Bart Keijser; Susan Huse; John Rossen; Reinier Veenhoven; Elske van Gils; Jacob Bruin; Roy Montijn; Marc Bonten; Elisabeth Sanders Journal: PLoS One Date: 2011-02-28 Impact factor: 3.240
Authors: Thanit Chalermwatanachai; Ramiro Vilchez-Vargas; Gabriele Holtappels; Tim Lacoere; Ruy Jáuregui; Frederiek-Maarten Kerckhof; Dietmar H Pieper; Tom Van de Wiele; Mario Vaneechoutte; Thibaut Van Zele; Claus Bachert Journal: Sci Rep Date: 2018-05-21 Impact factor: 4.379
Authors: Ji Heui Kim; Sung Hee Kim; Ji Youn Lim; Doyeon Kim; In Seong Jeong; Dong Kyu Lee; Yong Ju Jang Journal: Exp Mol Med Date: 2020-06-29 Impact factor: 8.718
Authors: Do-Yeon Cho; Calvin Mackey; William J Van Der Pol; Daniel Skinner; Casey D Morrow; Trenton R Schoeb; Steven M Rowe; William E Swords; Guillermo J Tearney; Bradford A Woodworth Journal: Front Cell Infect Microbiol Date: 2018-01-12 Impact factor: 5.293
Authors: Thomas Radulesco; Jerome R Lechien; Sven Saussez; Claire Hopkins; Justin Michel Journal: Ear Nose Throat J Date: 2020-08-27 Impact factor: 1.697
Authors: Ioannis Koutsourelakis; Ashleigh Halderman; Syed Khalil; Lauren E Hittle; Emmanuel F Mongodin; Andrew P Lane Journal: BMC Infect Dis Date: 2018-08-30 Impact factor: 3.090